Navigation Links
Hyperthyroidism linked to increased risk of hospitalization for heart and blood-vessel disease
Date:6/23/2012

An overactive thyroid gland, or hyperthyroidism, may increase the risk of hospitalization for heart and blood-vessel disease even after surgery to remove the gland, according to a new study. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.

"Overactive thyroid gland has long-lasting effects on the patient's heart and vessels," said study principal investigator Saara Metso, M.D., Ph.D. assistant chief of endocrinology in the Department of Internal Medicine, Division of Endocrinology, at Tampere University Hospital in Tampere, Finland. "Therefore, it is important to monitor the patient's heartbeat and blood pressure even years after the overactive thyroid gland has been cured."

The thyroid gland, located in the front of the neck, produces thyroid hormone, which helps regulate the process of turning food into energy. When the gland is overactive and produces excessive hormone, many bodily processes speed up. Symptoms include unexplained weight loss, rapid heart rate, increased appetite, profuse sweating, and feelings of anxiety.

Diagnosis of an overactive thyroid gland usually involves a simple blood test, and effective treatments are available. These include radioactive iodine, which destroys part of the thyroid gland; antithyroid medication to reduce thyroid-hormone synthesis; and surgery, or a thyroidectomy, to remove it.

Recently, however, questions were raised about the long-term health effects of treatment after some studies found that patients who had received radioactive iodine treatment or antithyroid medication had an increased risk of hospitalization for heart and blood-vessel disease. This risk persisted long after therapy ended, but it was unclear whether it was associated with the treatment itself or the prior overactive thyroid.

In findings implicating the disease rather than the treatment, the current study showed that patients who had undergone surgical thyroid removal also were at greater risk of being hospitalized for heart and blood-vessel disease. Overall, their risk was 17 percent greater compared to those without a history of overactive thyroid, and the increased risk persisted for as long as two decades after surgery.

"Although overactive thyroid gland is usually easy to diagnose and treat, it may be injurious to the patient's heart and vessels," Metso said. "It is probably the disease rather than the treatment that affects the patient's heart and vessels permanently."

Participants included 4,334 patients diagnosed with overactive thyroid who underwent thyroidectomy in Finland between 1986 and 2007, and 12,991 age- and gender-matched controls. They were 86 percent female, their average age was 46 years, and all were white. Average follow-up was 10.5 years.

Investigators obtained hospitalization information from Finland's national Hospital Discharge Registry for the study. They received funding from Research Funding of the Pirkanmaa Hospital District, Finland.

Hyperthyroidism affects approximately 1 percent of the U.S. population. The most common cause is an autoimmune disorder called Grave's disease.


'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Related medicine news :

1. Antibiotics Linked to Retinal Detachment Risk
2. Pesticides May Be Linked to Slightly Smaller Babies, Shorter Pregnancies
3. Pharmacy Robots Linked to Bacterial Contamination of Drugs
4. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
5. Dental X-Rays May Be Linked to Benign Brain Tumors
6. In Mice, Drug Reverses Symptoms of Condition Linked to Autism
7. Huntingtons Disease Linked to Reduced Cancer Risk in Study
8. Study finds significant skull differences between closely linked groups
9. Researchers Map Brain Regions Linked to Intelligence
10. Swallowing exercises linked with short-term improvement among patients with head and neck cancer
11. Anxiety Linked to Smarts in Brain Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Appleton, Wis. (PRWEB) , ... February 12, 2016 ... ... its second Lean Leadership Series at Zuckerberg San Francisco General Hospital on April ... to practice new behaviors and create new habits. The workshops cover a broad ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Fisher House Foundation ... Mayor John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns ... the VA Southern Nevada Healthcare System. This will be the first Fisher House ...
(Date:2/12/2016)... ... 12, 2016 , ... Vail knee specialist Robert LaPrade, MD, PhD ... . The list consists of physicians establishing, leading and partnering with ambulatory surgery centers ... An Ambulatory Surgery Center, also known as an ASC, is a modern health care ...
(Date:2/12/2016)... ... 12, 2016 , ... Donor Network West, the organ procurement organization that heals ... with San Ramon Regional Medical Center. Under the collaboration, the first of its kind, ... accommodate a more certain time frame for donor families for the recovery of organs. ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... surrounding communities by continuing it’s commitment to act as Agents of Change in ... works closely with area homeless families to fulfill immediate needs and help them ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
(Date:2/11/2016)... 11, 2016 Stem cells are primitive cells ... self-renewal and the capacity to differentiate into mature cell ... as the first mouse embryonic stem cells were derived ... 1995 that the first culturing of embryonic stem cells ... not produced until 2006 As a result of these ...
(Date:2/11/2016)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a biopharmaceutical ... pets, today announced the submission to FDA of the ... (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline results ... the control of pyrexia (fever) in horses were recently ... --> The Chemistry, Manufacturing, and Controls technical ...
Breaking Medicine Technology: